To further assess the diagnostic value of IFI44L methylation levels in GD, RA, SLE and SSc, we performed ROC curve analyses of all the DMS found on IFI44L between patients and matched controls in CD4+ and CD8+ T cells, respectively. The gene discussed is CD8A; the disease is systemic sclerosis.